Download presentation
Presentation is loading. Please wait.
Published byShannon Bryce Watkins Modified over 6 years ago
1
Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial Jean T Coulibaly, PhD, Gordana Panic, PhD, Kigbafori D Silué, PhD, Jana Kovač, MSc, Jan Hattendorf, PhD, Prof Jennifer Keiser, PhD The Lancet Global Health Volume 5, Issue 7, Pages e688-e698 (July 2017) DOI: /S X(17) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
2
Figure 1 Trial profile PSAC=preschool-aged children. SAC=school-aged children. S mansoni=Schistosomiasis mansoni. The Lancet Global Health 2017 5, e688-e698DOI: ( /S X(17) ) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
3
Figure 2 Cure rates in PSAC (blue lines) and SAC (red lines)
Circles show observed cure rates with 95% CIs (vertical lines). Numbers and colour code in the circles show geometric mean infection intensities at baseline (BL). Dashed lines represent the estimated dose–response curve and corresponding 95% confidence bands predicted by the Emax models. Epg=eggs per gram of stool. PSAC=preschool-aged children. SAC=school-aged children. The Lancet Global Health 2017 5, e688-e698DOI: ( /S X(17) ) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
4
Figure 3 Egg reduction rates in PSAC (blue lines) and SAC (red lines)
Diamonds show observed cure rates with 95% CIs (vertical lines). Dashed lines represent the estimated dose response curve and corresponding 95% confidence bands predicted by the Emax model. PSAC=preschool-aged children. SAC=school-aged children. The Lancet Global Health 2017 5, e688-e698DOI: ( /S X(17) ) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.